and in vivo infection studies with human hepatotropic viruses and preclinical evaluation of new therapeutic concepts within the Thematical Translation Unit Hepatitis as well as to support other Thematical

Kleinert H (2022) Cell Commun Signal. 20(1):47. https//doi.org/10.1186/s12964-022-00855-x Paving Therapeutic Avenues for FOXG1 Syndrome: Untangling Genotypes and Phenotypes from a Molecular Perspective. Akol

features in the adult human neocortex? Following this approach, we will investigate potential therapeutic strategies that efficiently target synaptic transmission and plasticity in the human brain. St

and numerous other membrane remodeling processes. Moreover, dynamin is a promising target for therapeutic intervention in chronic kidney diseases (CKDs). We want to provide the basis for novel strategies

: Prof. Dr. Hansmann, Pediatric Cardiology, OE 6730, project: Stem cell and anti-miR-mediated therapeutic interventions for pulmonary vascular disease and right ventricular failure Final exam June 2017

A. Rempen, H. Steiner, S. Tercanli, J. Wisser, K. S. Heling Gynäkologische Dysplasie-Einheit A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical In

bacteria and the lack of effective antiviral drugs represent a major problem. In particular, new therapeutic approaches are urgently needed for intracellular infections caused by facultative intracellular

Helmholtz Center Munich 13.12.2023 REBIRTH Kolloquium (1 pm s.t., online Vortrag) ‘RNA-based therapeutic strategies for liver injuries’ Prof. Dr. Amar Deep Sharma, Department of Gastroenterology, Hepatology [...] Clinic of Pneumology and Infectiology, MHH ´Genetic skewing of macrophage function to enhance the therapeutic properties’ Schifaa Abdin (Group of Prof. Dr. Nico Lachmann), Department of Applied Stem Cell and [...] for Kidney and Hypertension Diseases, MHH ´Relevance of cardiovascular risk factors for novel therapeutic approaches´ Prof. Dr. Rabea Hinkel, German Primate Centre, Leibniz Institute for Primate Research

Engineering at the same institute. Professor Figueiredo is highly interested in cell and gene therapeutic approaches in the field of transfusion and transplantation. She has a long-term expertise in the

Tsiavaliaris. Small molecule effectors of myosin motor proteins: novel pharmacological agents with therapeutic potential. Nov. 2018, Organisch-Chemisches Kolloquium der TU Dresden , Prof. Hans-Joachim Knölker